WorkingpartyProductinformationRoute ofadministrationProtocolassistanceSummary ofproductcharacteristicsType IIvariationTrialprotocolProduct-specificwaiverRegulatoryauthorityScientificadviceRiskmanagementsystemRe-examinationWorksharingSubgroupanalysisType IAvariationTissue-engineeredproductSummaryof opinionRiskminimisationactivityRapporteurScientificadvisorygroupWithdrawalperiodVariationWell-establisheduseRequest forsupplementaryinformationThirdcountrySpecimenRiskmanagementplanRenewalFree!SpecificobligationsTransfer ofmarketingauthorisationSupplementaryprotectioncertificateReferenceMemberStateReferralSunsetclauseType IBvariationSeriousadversereactionSomaticcell basedmedicineSafetysignalUrgentsafetyrestrictionReflectionpaperWorkingpartyProductinformationRoute ofadministrationProtocolassistanceSummary ofproductcharacteristicsType IIvariationTrialprotocolProduct-specificwaiverRegulatoryauthorityScientificadviceRiskmanagementsystemRe-examinationWorksharingSubgroupanalysisType IAvariationTissue-engineeredproductSummaryof opinionRiskminimisationactivityRapporteurScientificadvisorygroupWithdrawalperiodVariationWell-establisheduseRequest forsupplementaryinformationThirdcountrySpecimenRiskmanagementplanRenewalFree!SpecificobligationsTransfer ofmarketingauthorisationSupplementaryprotectioncertificateReferenceMemberStateReferralSunsetclauseType IBvariationSeriousadversereactionSomaticcell basedmedicineSafetysignalUrgentsafetyrestrictionReflectionpaper

Regulatory Bingo - Call List

(Print) Use this randomly generated list as your call list when playing the game. There is no need to say the BINGO column name. Place some kind of mark (like an X, a checkmark, a dot, tally mark, etc) on each cell as you announce it, to keep track. You can also cut out each item, place them in a bag and pull words from the bag.


1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
  1. Working party
  2. Product information
  3. Route of administration
  4. Protocol assistance
  5. Summary of product characteristics
  6. Type II variation
  7. Trial protocol
  8. Product-specific waiver
  9. Regulatory authority
  10. Scientific advice
  11. Risk management system
  12. Re-examination
  13. Worksharing
  14. Subgroup analysis
  15. Type IA variation
  16. Tissue-engineered product
  17. Summary of opinion
  18. Risk minimisation activity
  19. Rapporteur
  20. Scientific advisory group
  21. Withdrawal period
  22. Variation
  23. Well-established use
  24. Request for supplementary information
  25. Third country
  26. Specimen
  27. Risk management plan
  28. Renewal
  29. Free!
  30. Specific obligations
  31. Transfer of marketing authorisation
  32. Supplementary protection certificate
  33. Reference Member State
  34. Referral
  35. Sunset clause
  36. Type IB variation
  37. Serious adverse reaction
  38. Somatic cell based medicine
  39. Safety signal
  40. Urgent safety restriction
  41. Reflection paper